Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · IEX Real-Time Price · USD
7.85
+0.10 (1.29%)
At close: Jul 19, 2024, 4:00 PM
7.79
-0.06 (-0.83%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Ocular Therapeutix Revenue

Ocular Therapeutix had revenue of $59.84M in the twelve months ending March 31, 2024, with 15.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $14.77M with 10.47% year-over-year growth. In the year 2023, Ocular Therapeutix had annual revenue of $58.44M with 13.49% growth.

Revenue (ttm)
$59.84M
Revenue Growth
+15.79%
P/S Ratio
20.32
Revenue / Employee
$224,127
Employees
267
Market Cap
1.22B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.44M6.95M13.49%
Dec 31, 202251.49M7.97M18.32%
Dec 31, 202143.52M26.12M150.08%
Dec 31, 202017.40M13.18M311.71%
Dec 31, 20194.23M2.24M112.41%
Dec 31, 20181.99M67.00K3.48%
Dec 31, 20171.92M36.00K1.91%
Dec 31, 20161.89M137.00K7.83%
Dec 31, 20151.75M978.00K126.68%
Dec 31, 2014772.00K--
Dec 31, 20130--
Dec 31, 201210.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Omnicell 1.10B
AtriCure 414.60M
Artivion 368.21M
Maravai LifeSciences Holdings 274.10M
Xencor 162.18M
Ardelyx 159.11M
Establishment Labs Holdings 155.79M
Prothena Corporation 89.25M
Revenue Rankings